Viridian Therapeutics, Inc. (VRDN) SEC filings
VRDN SEC filings moved a median of +1.41% by the close. VRDN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the VRDN overview →
69 measured VRDN SEC filing events.
Where these VRDN SEC filings landedvs 69 measured VRDN SEC filing reactions
| Middle 50% of VRDN SEC filing reactions | -1.50% to +3.40% |
|---|---|
| Median reaction (to close) | +1.41% |
| Measured reactions | 69 |
Point-in-time · zero look-ahead
Half of the 69 VRDN SEC filing events with a measured close landed between -1.50% and +3.40%; 62% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Viridian Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.05% | +9.64% | |
| Form 8-K Viridian Therapeutics, For: Aug 06 | SEC filing · Form 8-K | +2.05% | +9.64% | |
| Form 8-K Viridian Therapeutics, For: Jun 26 | SEC filing · Form 8-K | +1.47% | -1.57% | |
| Form 8-K Viridian Therapeutics, For: Jun 02 | SEC filing · Form 8-K | +1.65% | +3.55% | |
| Form 8-K Viridian Therapeutics, For: May 27 | SEC filing · Form 8-K | -0.29% | +1.50% | |
| Form 8-K Viridian Therapeutics, For: May 24 | SEC filing · Form 8-K | -0.81% | -0.06% | |
| Form 8-K Viridian Therapeutics, For: May 06 | SEC filing · Form 8-K | -1.07% | -2.09% | |
| Form 305B2 Viridian Therapeutics, | SEC filing · Form 305B2 | -3.19% | -3.19% | |
| Form 10-Q Viridian Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.51% | +1.41% | |
| Form 8-K Viridian Therapeutics, For: May 05 | SEC filing · Form 8-K | +1.51% | +1.41% | |
| Form ARS Viridian Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.20% | -0.94% | |
| Form DEF 14A Viridian Therapeutics, For: Jun 02 | SEC filing · Form DEF | -0.20% | -0.94% | |
| Form DEFA14A Viridian Therapeutics, | SEC filing · Form DEFA14A | -0.20% | -0.94% | |
| Form 8-K Viridian Therapeutics, For: Mar 30 | SEC filing · Form 8-K | +7.76% | +9.00% | |
| Form 10-K Viridian Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.33% | +9.02% | |
| Form 8-K Viridian Therapeutics, For: Feb 26 | SEC filing · Form 8-K | +0.33% | +9.02% | |
| Form S-8 Viridian Therapeutics, | SEC filing · Form S-8 | +1.69% | +1.27% | |
| Form 10-Q Viridian Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.17% | +4.99% | |
| Form 8-K Viridian Therapeutics, For: Nov 05 | SEC filing · Form 8-K | +0.17% | +4.99% | |
| Form 8-K Viridian Therapeutics, For: Oct 21 | SEC filing · Form 8-K | +0.16% | +0.78% | |
| Form 8-K Viridian Therapeutics, For: Oct 21 | SEC filing · Form 8-K | -1.30% | -8.06% | |
| Form 8-K Viridian Therapeutics, For: Oct 17 | SEC filing · Form 8-K | +0.61% | -1.79% | |
| Form S-3ASR Viridian Therapeutics, | SEC filing · Form S-3ASR | +0.40% | +0.65% | |
| Form 10-Q Viridian Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -2.17% | -3.04% | |
| Form 8-K Viridian Therapeutics, For: Aug 06 | SEC filing · Form 8-K | -2.17% | -3.04% | |
| Form S-8 Viridian Therapeutics, | SEC filing · Form S-8 | -1.13% | -4.01% | |
| Form 8-K Viridian Therapeutics, For: Jul 30 | SEC filing · Form 8-K | -0.95% | -0.17% | |
| Form 8-K Viridian Therapeutics, For: Jun 20 | SEC filing · Form 8-K | -1.13% | +0.55% | |
| Form 8-K Viridian Therapeutics, For: May 20 | SEC filing · Form 8-K | +0.78% | +7.21% | |
| Form 10-Q Viridian Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.04% | -7.03% | |
| Form 8-K Viridian Therapeutics, For: May 06 | SEC filing · Form 8-K | +0.04% | -7.03% | |
| Form ARS Viridian Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.19% | +1.50% | |
| Form DEF 14A Viridian Therapeutics, For: Jun 20 | SEC filing · Form DEF | -0.19% | +1.50% | |
| Form DEFA14A Viridian Therapeutics, | SEC filing · Form DEFA14A | -0.19% | +1.50% | |
| Form 8-K Viridian Therapeutics, For: Apr 02 | SEC filing · Form 8-K | -0.17% | +1.99% | |
| Form 8-K Viridian Therapeutics, For: Mar 05 | SEC filing · Form 8-K | -0.16% | +4.14% | |
| Form 8-K Viridian Therapeutics, For: Mar 03 | SEC filing · Form 8-K | -0.98% | +6.47% | |
| Form 10-K Viridian Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.26% | -7.63% | |
| Form S-8 Viridian Therapeutics, | SEC filing · Form S-8 | -0.98% | +6.47% | |
| Form 8-K Viridian Therapeutics, For: Feb 27 | SEC filing · Form 8-K | +1.04% | -1.04% | |
| Form 8-K Viridian Therapeutics, For: Jan 07 | SEC filing · Form 8-K | -0.67% | -1.50% | |
| Form 8-K Viridian Therapeutics, For: Dec 16 | SEC filing · Form 8-K | +3.70% | +2.13% | |
| Form 10-Q Viridian Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -6.73% | -17.05% | |
| Form 8-K Viridian Therapeutics, For: Nov 12 | SEC filing · Form 8-K | -6.73% | -17.05% | |
| Form 8-K Viridian Therapeutics, For: Sep 11 | SEC filing · Form 8-K | +0.37% | +2.08% | |
| Form 8-K Viridian Therapeutics, For: Sep 10 | SEC filing · Form 8-K | -2.17% | +16.46% | |
| Form S-8 Viridian Therapeutics, | SEC filing · Form S-8 | -2.41% | -4.11% | |
| Form 10-Q Viridian Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.30% | +3.35% | |
| Form 8-K Viridian Therapeutics, For: Aug 08 | SEC filing · Form 8-K | +1.30% | +3.35% | |
| Form 8-K Viridian Therapeutics, For: Jul 15 | SEC filing · Form 8-K | +1.38% | +6.76% | |
| Form 8-K Viridian Therapeutics, For: Jun 17 | SEC filing · Form 8-K | +2.10% | +1.37% | |
| Form DEFA14A Viridian Therapeutics, | SEC filing · Form DEFA14A | +1.27% | +3.12% | |
| Form 10-Q Viridian Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -2.00% | -3.93% | |
| Form 8-K Viridian Therapeutics, For: May 08 | SEC filing · Form 8-K | -2.00% | -3.93% | |
| Form ARS Viridian Therapeutics, For: Dec 31 | SEC filing · Form ARS | -2.28% | +1.10% | |
| Form DEF 14A Viridian Therapeutics, For: Jun 17 | SEC filing · Form DEF | -2.28% | +1.10% | |
| Form DEFA14A Viridian Therapeutics, | SEC filing · Form DEFA14A | -2.28% | +1.10% | |
| Form 8-K Viridian Therapeutics, For: Apr 10 | SEC filing · Form 8-K | -0.26% | -0.79% | |
| Form S-8 Viridian Therapeutics, | SEC filing · Form S-8 | -0.81% | -10.31% | |
| Form 10-K Viridian Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.74% | +3.33% | |
| Form 8-K Viridian Therapeutics, For: Feb 27 | SEC filing · Form 8-K | +2.74% | +3.33% | |
| Form 8-K Viridian Therapeutics, For: Jan 17 | SEC filing · Form 8-K | +0.92% | -0.20% | |
| Form 8-K Viridian Therapeutics, For: Jan 03 | SEC filing · Form 8-K | -0.62% | +8.65% | |
| Form 8-K Viridian Therapeutics, For: Dec 15 | SEC filing · Form 8-K | +0.67% | +8.39% | |
| Form S-3ASR Viridian Therapeutics, | SEC filing · Form S-3ASR | -1.56% | +3.11% | |
| Form 10-Q Viridian Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.50% | +3.40% | |
| Form 8-K Viridian Therapeutics, For: Nov 13 | SEC filing · Form 8-K | +1.50% | +3.40% | |
| Form 8-K Viridian Therapeutics, For: Oct 29 | SEC filing · Form 8-K | +0.76% | +4.76% | |
| Form 8-K Viridian Therapeutics, For: Oct 29 | SEC filing · Form 8-K | +7.58% | +3.25% |
Keep exploring
More VRDN: earnings → · analyst actions → · VRDN overview →